TA
Tazeen Ahmad B of A Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Incyte
INCY
$16.7B
| $85.44 | $104 |
22%
upside
| Buy | 10 hours ago |
|
2
Ascendis Pharma
ASND
$12B
| $198.13 | $230 |
16%
upside
| Buy | 2 days ago |
|
3
argenx
ARGX
$44.9B
| $733.66 | $887 |
21%
upside
| Buy | 2 days ago |
|
4
Sarepta Therapeutics
SRPT
$1.93B
| $18.46 | $16 |
13%
downside
| Underperform | 14 days ago |
|
5
PTC Therapeutics
PTCT
$4.61B
| $58.01 | $76 |
31%
upside
| Buy | 15 days ago |
|
6
BioNTech
BNTX
$24.9B
| $103.50 | $134 |
29%
upside
| Buy | 1 month ago |
|
7
Apellis Pharmaceuticals
APLS
$3.62B
| $28.65 | $24 |
16%
downside
| Neutral | 1 month ago |
|
8
Alnylam Pharmaceuticals
ALNY
$59.4B
| $453.54 | $359 |
21%
downside
| Buy | 1 month ago |
|
9
Taysha Gene Therapies
TSHA
$889M
| $3.26 | $8 |
145%
upside
| Buy | 1 month ago |
|
10
Rhythm Pharmaceuticals
RYTM
$6.95B
| $104.57 | $95 |
9%
downside
| Buy | 1 month ago |
|
11
BioCryst Pharmaceuticals
BCRX
$1.74B
| $8.27 | $15 |
81%
upside
| Buy | 2 months ago |
|
12
Acadia Pharmaceuticals
ACAD
$4.3B
| $25.50 | $23 |
10%
downside
| Neutral | 3 months ago |
|
13
Prothena Corp
PRTA
$442M
| $8.21 | $4 |
51%
downside
| Underperform | 3 months ago |
|
14
Denali Therapeutics
DNLI
$2.16B
| $14.79 | $27 |
83%
upside
| Buy | 3 months ago |
|
15
Arvinas
ARVN
$559M
| $7.61 | $28 |
268%
upside
| Buy | 5 months ago |
|
16
Merus
MRUS
$5.01B
| $66.23 | $70 |
6%
upside
| Buy | 5 months ago |
|
17
4D Molecular Therapeutics
FDMT
$309M
| $6.61 | $40 |
505%
upside
| Buy | 5 months ago |
|
18
Neurocrine Biosciences
NBIX
$13.9B
| $140.40 | $179 |
27%
upside
| Buy | 6 months ago |
|
19
KalVista Pharmaceuticals
KALV
$765M
| $15.20 | $22 |
45%
upside
| Buy | 8 months ago |
|
20
Amicus Therapeutics
FOLD
$2.47B
| $8.02 | $15 |
87%
upside
| Buy | 10 months ago |
|
21
Fulcrum Therapeutics
FULC
$372M
| $6.88 | $2 |
71%
downside
| Underperform | 11 months ago |
|
22
Ultragenyx Pharmaceutical
RARE
$3.01B
| $31.28 | $76 |
143%
upside
| Buy | 1 year ago |
|
23
Ocular Therapeutix
OCUL
$2.21B
| $12.70 | $15 |
18%
upside
| Buy | 1 year ago |
|
24
Pharvaris
PHVS
$1.41B
| $21.98 | $11 |
50%
downside
| Underperform | 1 year ago |
|
25
ADC Therapeutics
ADCT
$382M
| $3.40 | $2 |
41%
downside
| Underperform | 2 years ago |
|